Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Physicians who Perform Radiosurgery (US)

Articles with lock require a subscription to GLG News | Request a free trial
Charles BennettApril 4, 2008
Advantages of SenoRx Contura over Mammosite Breast Brachytherapy system.
Analysis of: A new player in the growing Breast Brachytherapy field | www.senorx.com
Author: Charles Bennett, Radiation Oncologist , Robert Boissoneault Oncology Institute
SenoRx has released the Contura system which provides a superior system when compared to the Mammosite Breast Brachytherapy System.  These advantages include: 1.  Better dosimetry, opening the door for more patients to be treated by avoiding the elimination of some patients due to skin spacing...
November 16, 2007
This trial confirms zevalin's effectiveness - limited prescribing remains a block to timely use.
Analysis of: Major Phase 3 Trial Shows Zevalin(R) Extends Progression-Free Survival in one of the most common types of Lymphoma | www.pipelinereview.com
Author: GLG Expert Contributor
Zevalin represents the first of an exciting new class of drugs which in many ways can be thought of as a chemotheurapeutic agent though the cell death mechanism is ionizing radiation. With a high response rate (82%) and a low toxicity -reversable hematologic effect only, it has the potential to be a...
November 8, 2007
Varian's New Rapid Arc VMAT(Volumetric Modulated Arc Therapy) Technology
Analysis of: Varian's New Rapid Arc Delivery | www.varian.com
Author: Lawrence Tena, Radiation Oncologist, St. Vincent's Comprehensive Cancer Center
VMAT is the answer to Tomotherapy and more. This new VMAT technology improves on current IMRT and Tomotherapy.
July 26, 2007
Tomotherapy (ttpy) enters mainstream
Analysis of: Cancer Therapy Chain buying six Tomotherapy systems | news.moneycentral.msn.com
Author: GLG Expert Contributor
This news release is significant for analyzing market share of radiation therapy systems as it relates to Varian, Elekta and Tomotherapy
July 2, 2007
Comments
Analysis of: Mail order drugs flying off shelves | www.gazette.com
Author: Louis Rocco, System Director of Purchasing , Hallmark Health System, Inc
I could not agree more that people should have a choice and maybe the pricing markey is the US will finally drop after how it see it will work all pharmacies across the country. The manufacturers need to be held responsible for this issue, they caused it with raising prices and making more of a profit....

Page : 11 to 5 of 5

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T21:45:56.203